Levomilnacipran
- Product NDC
- 65162-411
- 11-digit product format
- 651620411
- Labeler code
- 65162
- Product ID
- 65162-411_9271952e-b176-4c38-90e8-322c714be99d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levomilnacipran
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA210790
- Marketing category
- ANDA
- Marketing start
- 2019-02-04
- Marketing end
- 0000-00-00
- Substance
- LEVOMILNACIPRAN HYDROCHLORIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-411 | LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS LLC] | 7 | Legacy NDC | 20240719_bcbc5d92-e022-4a0d-ab4d-2b0d7aa68c58.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-411-03 | 65162041103 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-411-03) | 2019-02-04 | 0000-00-00 | No | No | Current |